Subgroup analysis in RAISE: A randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression

Radka Obermannová, E. Van Cutsem, T. Yoshino, G. Bodoky, J. Prausová, R. Garcia-Carbonero, T. Ciuleanu, P. Garcia Alfonso, D. Portnoy, A. Cohn, K. Yamazaki, P. Clingan, S. Lonardi, T. W. Kim, L. Yang, F. Nasroulah, J. Tabernero

Research output: Contribution to journalArticleResearchpeer-review

25 Citations (Scopus)

Fingerprint Dive into the research topics of 'Subgroup analysis in RAISE: A randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression'. Together they form a unique fingerprint.

Medicine & Life Sciences